Max-Delbrueck-Centrum is a company that provides Molecular medicine, Antibody-drug conjugate, Monoclonal antibody and more. Max-Delbrueck-Centrum is headquartered in DE BE. Max-Delbrueck-Centrum was founded in 1992. Max-Delbrueck-Centrum has a total of 3 patents and 7,388 literature
Related Topics
Molecular medicineAntibody-drug conjugateMonoclonal antibodyOncology drugs